AVIVA STRATEGIES (FKA MGB CONSULTING)

Lobbying for TAYSHA GENE THERAPIES · biotechnology

Filing Registration

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Dec 11, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Texas

Lobbying activity 1

Health Issues

Health insurance reform, affordability of medicines, biotech innovation

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.